Edwards Lifesciences Profit Margin 2010-2024 | EW

Current and historical gross margin, operating margin and net profit margin for Edwards Lifesciences (EW) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Edwards Lifesciences net profit margin as of September 30, 2024 is 70.82%.
Edwards Lifesciences Annual Profit Margins
Edwards Lifesciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.156B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.066B 26.11
Intuitive Surgical (ISRG) United States $211.086B 110.36
Alcon (ALC) Switzerland $41.615B 27.84
IQVIA Holdings (IQV) United States $35.821B 19.74
IDEXX Laboratories (IDXX) United States $34.331B 40.43
DexCom (DXCM) United States $32.958B 49.63
Waters (WAT) United States $23.988B 35.47
STERIS (STE) Ireland $20.691B 23.82
SONOVA HOLDING (SONVY) Switzerland $19.710B 0.00
Hologic (HOLX) United States $15.740B 17.09
Fresenius Medical Care AG KGaA (FMS) Germany $13.538B 13.90
Globus Medical (GMED) United States $12.364B 31.31
Sysmex ADR (SSMXY) Japan $11.726B 0.00
Penumbra (PEN) United States $10.120B 99.13
Masimo (MASI) United States $9.225B 44.63
Glaukos (GKOS) United States $8.623B 0.00
Teleflex (TFX) United States $8.419B 13.43
Integer Holdings (ITGR) United States $4.729B 26.81
Inari Medical (NARI) United States $4.657B 0.00
PROCEPT BioRobotics (PRCT) United States $3.967B 0.00
Veracyte (VCYT) United States $3.145B 94.37
Nihon Kohden (NHNKY) Japan $2.658B 20.19
LivaNova (LIVN) United Kingdom $2.623B 15.14
Tandem Diabetes Care (TNDM) United States $2.309B 0.00
Elekta AB (EKTAY) Sweden $2.167B 19.48
TransMedics (TMDX) United States $1.920B 60.85
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
Alphatec Holdings (ATEC) United States $1.641B 0.00
Artivion (AORT) United States $1.288B 85.33
RxSight (RXST) United States $1.225B 0.00
Pulse Biosciences (PLSE) United States $1.083B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.911B 0.00
AxoGen (AXGN) United States $0.796B 0.00
Mesa Laboratories (MLAB) United States $0.758B 17.88
IRadimed (IRMD) United States $0.750B 40.53
AVANOS MEDICAL, INC (AVNS) United States $0.732B 12.44
SiBone (SIBN) United States $0.700B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.693B 0.00
OrthoPediatrics (KIDS) United States $0.658B 0.00
Semler Scientific (SMLR) United States $0.599B 31.55
Treace Medical Concepts (TMCI) United States $0.543B 0.00
AngioDynamics (ANGO) United States $0.503B 0.00
Delcath Systems (DCTH) United States $0.458B 0.00
Pacific Biosciences Of California (PACB) United States $0.449B 0.00
CVRx (CVRX) United States $0.428B 0.00
Tactile Systems Technology (TCMD) United States $0.418B 22.60
ClearPoint Neuro (CLPT) United States $0.415B 0.00
NeuroPace (NPCE) United States $0.357B 0.00
Alpha Tau Medical (DRTS) Israel $0.273B 0.00
Inogen (INGN) United States $0.249B 0.00
Accuray (ARAY) United States $0.225B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.171B 0.00
Sight Sciences (SGHT) United States $0.144B 0.00
Sensus Healthcare (SRTS) United States $0.108B 11.51
Atossa Genetics (ATOS) United States $0.104B 0.00
908 Devices (MASS) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Vicarious Surgical (RBOT) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
Neuronetics (STIM) United States $0.075B 0.00
WORK Medical Technology Group (WOK) China $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
InspireMD (NSPR) Israel $0.071B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.93
Baird Medical Investment Holdings (BDMD) $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Microbot Medical (MBOT) United States $0.033B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.027B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.008B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00